Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
American Journal of Industrial Medicine
|
September 6, 2005
New workers' compensation legislation: expected pharmaceutical cost savings
Leslie Wilson, Matthew Gitlin
American Journal of Industrial Medicine
|
March 21, 2007
Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing
Matthew Gitlin, Leslie Wilson
Pharmacotherapy
|
November 25, 2005
Gabapentin-induced neurologic toxicities
Thomas Bookwalter, Matthew Gitlin
Transplantation and Cellular Therapy
|
October 22, 2022
A Model to Estimate Cytokine Release Syndrome and Neurological Event Management Costs Associated With CAR T-Cell Therapy
Jack Badaracco, Matthew Gitlin, Scott J Keating
Hemodialysis International. International Symposium on Home Hemodialysis
|
July 22, 2008
Factors affecting anemia management in hemodialysis patients: a single-center experience
David M Spiegel, Matthew Gitlin, Tracy Mayne
Journal of Managed Care & Specialty Pharmacy
|
June 5, 2023
Time duration and health care resource use during cancer diagnoses in the United States: A large claims database analysis
Matthew Gitlin, November McGarvey, Namrata Shivaprakash, et al.
Archives of Osteoporosis
|
October 13, 2021
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in Japan: a simulation projection model from 2020 to 2040
Hiroshi Hagino, Micah Jackson, Matthew Gitlin, et al.
Archives of Osteoporosis
|
July 28, 2021
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in South Korea: a simulation projection model from 2020 to 2040
Micah Jackson, Kyu Hyun Yang, Matthew Gitlin, et al.
Journal of Medical Economics
|
November 1, 2023
Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States
November McGarvey, Matthew Gitlin, Ela Fadli, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 14, 2017
The value of open access and a patient centric approach to oral oncolytic utilization in the treatment of Chronic Myelogenous Leukemia: A U.S. perspective
Lopamudra Das, Matthew Gitlin, Lisa R Siegartel, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
American Journal of Industrial Medicine
|
September 6, 2005
New workers' compensation legislation: expected pharmaceutical cost savings
Leslie Wilson, Matthew Gitlin
American Journal of Industrial Medicine
|
March 21, 2007
Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing
Matthew Gitlin, Leslie Wilson
Pharmacotherapy
|
November 25, 2005
Gabapentin-induced neurologic toxicities
Thomas Bookwalter, Matthew Gitlin
Transplantation and Cellular Therapy
|
October 22, 2022
A Model to Estimate Cytokine Release Syndrome and Neurological Event Management Costs Associated With CAR T-Cell Therapy
Jack Badaracco, Matthew Gitlin, Scott J Keating
Hemodialysis International. International Symposium on Home Hemodialysis
|
July 22, 2008
Factors affecting anemia management in hemodialysis patients: a single-center experience
David M Spiegel, Matthew Gitlin, Tracy Mayne
Journal of Managed Care & Specialty Pharmacy
|
June 5, 2023
Time duration and health care resource use during cancer diagnoses in the United States: A large claims database analysis
Matthew Gitlin, November McGarvey, Namrata Shivaprakash, et al.
Archives of Osteoporosis
|
October 13, 2021
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in Japan: a simulation projection model from 2020 to 2040
Hiroshi Hagino, Micah Jackson, Matthew Gitlin, et al.
Archives of Osteoporosis
|
July 28, 2021
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in South Korea: a simulation projection model from 2020 to 2040
Micah Jackson, Kyu Hyun Yang, Matthew Gitlin, et al.
Journal of Medical Economics
|
November 1, 2023
Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States
November McGarvey, Matthew Gitlin, Ela Fadli, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 14, 2017
The value of open access and a patient centric approach to oral oncolytic utilization in the treatment of Chronic Myelogenous Leukemia: A U.S. perspective
Lopamudra Das, Matthew Gitlin, Lisa R Siegartel, et al.
Page
of 6